TLR4 and head and neck cancer: The data from TCGA showed that TLR4 is expressed in head and neck cancer as a non-mutated diploid occurrence (~96%) (Figure 5A,B), indicating that the TRL receptor can serve as a functional receptor, especially in HPV (+) tumors.